CITIGROUP INC: SCS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITIGROUP INC on SCS, newest first. How the timeline and the estimate are built.
CITIGROUP INC held 0 SCS shares at 2025-12-31 per its 13F-HR filed 2026-02-13.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -1,649,892 shares
13F-HR 0000831001-26-000006 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 1,649,892 sharesChange vs previous 13F +1,601,503 shares
0.02% of the 13F portfolio, value $28,378,142.
13F-HR 0000831001-25-000158 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 48,389 sharesChange vs previous 13F -37,118 shares
<0.01% of the 13F portfolio, value $504,698.
13F-HR 0000831001-25-000145 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 85,507 sharesChange vs previous 13F -1,858 shares
<0.01% of the 13F portfolio, value $937,157.
13F-HR 0000831001-25-000103 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 87,365 sharesChange vs previous 13F +4,388 shares
<0.01% of the 13F portfolio, value $1,032,654.
13F-HR 0000831001-25-000062 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 82,977 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,119,360.
13F-HR 0000831001-24-000148 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).